Neuroattenuated variants of mouse hepatitis virus type 4 (MHV-4) selected for resistance to neutralizing monoclonal antibodies (R. G. Dalziel, P. W. Lampert, P. J. Talbot, and M. J. Buchmeier, J. Virol. 59:463-471, 1986) were found to harbor large deletions in both mRNA 3 and its protein product, the 180-kilodalton virion spike (S) glycoprotein. By using antipeptide antibodies directed against selected portions of the chain, deletions were mapped to the middle of the amino-terminal Sl fragment, one of the two posttranslational cleavage products of S, and involved omission of 15 kilodaltons of protein. Deletion mutants could be selected only after multiple passage of virus through cultured cell lines; minimaHly passaged MHV-4 stocks contained putative point mutants selectable by neutralizing monoclonal antibodies but no deletions. Enhanced growth of deletion mutants relative to wild-type virus was observed in four cell lines used for virus propagation and was attributed to delayed and diminished cytopathic effects that allowed cultures to support virus production for prolonged periods. This hypothesis was reinforced by the finding that no selective advantage for the deletion mutants was observed in two cell lines resistant to virus-induced cytopathic effects. These results indicate that the passaging of MHV-4 in culture generates heterogeneity in S structure and eventually selects for rare neutralization-resistant deletion mutants with decreased virulence properties.
Mouse hepatitis virus type 4 (MHV-4; strain JHM) is a neurotropic member of the family Coronaviridae. Intracerebral inoculation of mice with this virus typically results in a rapidly fatal encephalomyelitis (1) . Variants of  however, have been generated by chemical mutagenesis (11) , growth in persistently infected cell culture (2, 12) , and multiple passage in mouse brain (31) . The resulting variants, selected for temperature sensitivity (11) or small-plaque morphology (31) , were often found to be attenuated in murine hosts. In most cases, infection with these mutants leads to a chronic sublethal demyelinating disease without encephalitis (11, 16) .
The correlation of genetic lesions on these variants with neuroattenuation has been hampered by selection methods that did not restrict the range of mutations to a single viral gene. However, multiple libraries of neutralizing monoclonal antibodies directed against the 180-kilodalton (kDa) spike glycoprotein (S; formerly termed E2) of MHV-4 have been prepared (8, 38, 39) , and these have served as selecting agents in the isolation of naturally occurring neutralizationresistant variants. Three separate studies addressing the selection and relative pathogenicity of these neutralizationresistant variants have shown that they possess a neuroattenuation phenotype similar to that seen with previously isolated variants (7, 9, 40) .
Although these studies showed that at least one determinant associated with neurovirulence of MHV-4 was present on S, they did not further define its location within the protein. Accumulated facts pertaining to the structure of coronavirions did, however, provide clues as to its position. S is known to comprise the characteristic spikes projecting 20 nm from the virion envelope. These spikes, which are thought to be dimers or trimers of S (5), serve as ligands in virus-cell receptor binding (6, 33) and when expressed on the cell surface have fusogenic activity that results in syncytium formation and recruitment of cells into the infection cycle (6, 10) . In contrast to S, the virion matrix glycoprotein M is largely embedded within the membrane, and phosphoprotein N (nucleocapsid) remains associated with the internal 26-kilobase RNA genome (33) . The 180-kDa S chain is cleaved posttranslationally into two 90-kDa fragments termed Sl and S2, previously termed 90B (Si) and 90A (S2) (34) . Both biochemical and amino acid sequence information has suggested that the carboxy-terminal S2 fragment is an integral membrane protein that comprises the stalk portion of the spikes, whereas the amino-terminal Si is a peripheral fragment that likely makes up the apices of the peplomers (29) . S is the most polymorphic of the three virion proteins (37) , and comparative analyses of the known amino acid sequences of S from MHV strains A59 (21) and JHM (28) (33) . Briefly, virus was absorbed to 90% confluent monolayers for 1 h at 37°C in growth medium. Unattached inoculum was then removed and replaced with fresh growth medium, and progress of infection was monitored by examination of syncytium development. At the indicated times after inoculation, virus-containing extracts were prepared by three freeze-thaw cycles (-70 to +20°C). Debris was then removed by low-speed centrifugation (5,000 x g for 15 min at 5°C), and the resulting clarified extracts were stored at -70°C. Infectivity in the extracts was determined by plaque titration on DBT cells. Where indicated, passaged stocks of MHV-4 were subjected to an additional three cycles of plaque purification on DBT cells, and virus from the final well-isolated plaque was amplified in Sac-cells as described above to generate a fresh working virus stock.
Selection of MAb-resistant variants. The monoclonal antibodies (MAbs) used were generated in this laboratory (6) , and their properties have been described elsewhere (38) . Original (1986) MAb-resistant variants were selected as described previously (7), and newly selected (1989) Electrophoresis of RNA was performed as described previously (24) 0.5% NP-40, 0.3 trypsin inhibitor units of aprotinin per ml, and 1 mM phenylmethylsulfonyl fluoride) and by subsequent clarification by centrifugation (14,000 x g for 2 min).
S was immunoprecipitated from the extracts with rabbit antiserum (kindly provided by K. Holmes, Uniformed Health Services, Bethesda, Md.) and staphylococcal protein A (15) . Samples (0.1 ml) were preabsorbed with 0.01 ml of a 10% (vol/vol) suspension of Pansorbin (CalbiochemBehring) in lysis buffer, clarified, and incubated with 0.001 ml of antiserum for 1 h at 22°C. A 0.025-ml amount of 10%
Pansorbin was added; 15 min later, the immune complexes were pelleted (14, mli slab gels containing 3% (wt/vol) and 8% (wt/vol) acrylamide in the stacking and resolving gel components, respectively. After electrophoresis (10 V/cm for 5 h), gels were soaked for 2 h in 10% acetic acid-25% methanol, vacuum dried, and exposed for 2 days to Kodak XAR-5 film.
Antipeptide antibodies. Three antipeptide antibodies were used. Each was directed against peptides derived from the sequence of the S protein of MHV A59. These were peptide A (CAQPDIVSPC; S amino acids 481 to 490), peptide B (CVDYSKSRRAHR; amino acids 706 to 717), and peptide C (SVSTGYRLTTC; amino acids 718 to 727). Peptides were synthesized, purified, linked to keyhole limpet hemocyanin, and used to immunize rabbits by previously described procedures (3). Anti-A and anti-C sera were used for Western blotting (immunoblotting) at 1:100 dilutions; anti-B serum was used at 1:500. For all antisera, specificity was demonstrated by blocking reactivity against S with free peptide as described elsewhere (3) .
Western blot analysis. Samples for Western blot analysis were prepared by concentrating virions from clarified infected-cell lysates. Lysates (10 ml) were underlaid successively with 9-ml volumes of 10, 20, and 30% (wt/wt) sucrose solutions in HNE buffer (0.05 M sodium N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [HEPES; pH 7.0], 0.1 M NaCl, 0.001 M EDTA) containing 0.01% bovine serum albumin, and then virions were pelleted through the sucrose solutions by using a Beckman Spinco SW28 rotor (25,000 rpm for 5 h at 5°C). Pellets were resuspended in 0.5 ml of ice-cold HNE buffer and stored at -70°C. (14) at 10 V/cm for 6 h without recirculation of the 0.01 M Tris base-0.01 M bicine-0.1% SDS running buffer. Unlike the discontinuous Laemmli gels, Tris-bicine gels permitted the penetration of high-molecular-weight oligomers of S into the resolving matrix. After electrophoresis, proteins were transferred electrophoretically as described previously (4) After transfer, the filters were preblocked overnight at 4°C in blotting buffer (phosphate-buffered saline containing 0.05% Tween 20 and 2% skimmed milk powder) (13) (Fig. 2, lanes 2 to 4 and lanes 6 and 7) . Both mutants synthesized S polypeptides 16 kDa smaller than wild-type virus when radiolabeling was done in the presence of the glycosylation inhibitor tunicamycin (data not shown), indicating that about 150 amino acids were deleted and that the small differences in mobility between the two mutant chains (15 versus 12 kDa smaller than wild-type S) resulted from differences in the extent of glycosylation. In addition, the migration of S from MHV-4 was slightly less than that from MHV A59 ( Fig. 2; compare lanes 2, 5, and 8 ). This observation, in conjunction with previous sequence information on S from MHV A59 and JHM (21, 28) , indicated that the order of S size on these strains is MHV-4 > MHV A59 > MHV JHM.
To localize these deletions to a specific region of S, we took advantage of the fact that S-polypeptide sequences have been deduced from the nucleotide sequences of both MHV A59 (21) and MHV JHM (28) . Using this information as well as the location of the proteolytic cleavage site of S, we synthesized peptides corresponding to three regions of the chain (Fig. 3) . Peptide A, which corresponds to residues near the middle of the MHV A59 S1 fragment, is not represented in MHV JHM S and thus represents a region of polymorphism between the two viruses. Peptides B and C represent the MHV A59 sequences flanking the arginine-rich S1-S2 cleavage site. After proteolysis, peptide B and C We anticipated that rabbit antisera raised against these three peptides would prove useful in the localization of S deletions in MHV-4 to fragment S1 or S2. Therefore, virion proteins from MHV strains and variants were tested for reactivity with the anti-peptide A, B, and C antisera by Western blot analysis. Anti-A serum (Fig. 3A) reacted with the Si chains of MHV-4 and MHV A59 but not with the variants V4B11.3A(86) and V5A13.1A(86). Strong binding to a previously unidentified band specific to MHV-4 at 75 kDa (designated p75) was also observed; this protein may represent an alternate S cleavage product. The signal at the position of nucleocapsid (N) was not specific, as judged by a failure to block this binding by prior saturation of antiserum with free peptide A (data not shown). Anti-B serum reacted with the S1 proteins of all four viruses; with the exception of the bands for V5A13.1A(86) and MHV A59, each S1 band had a characteristic electrophoretic mobility. Anti-C serum, which reacted strongly in the analysis, identified two major bands at about 90 and 270 kDa. These bands, which coelectrophoresed in all MHV strains and variants, likely represent monomers (90 kDa) and trimers (270 kDa) of S2. Together, these results indicate that the major deletions in our MAbresistant variants are located on fragment S1 and include a region that has been previously shown to be absent in MHV JHM.
Reselection of neutralization-resistant variants of MHV-4 yields both point and deletion mutants. Additional analyses of viral RNA and protein electropherotypes revealed that all of J. VIROL. After three rounds of neutralization, we characterized these newly selected populations by first analyzing their patterns of resistance to neutralizing S-specific MAbs. Unlike the deletion mutants, these 1989 variants displayed resistance only to the MAb used to select them (Table 2) . Second, the relative growth rates of the single-MAb-resistant variants were compared with wild-type MHV-4 and deletion mutant V5A13.1 in Sac-culture. After low-multiplicity infection, the deletion mutant grew to the highest yields (106 PFU/ml), followed by wild type MHV-4 and V5A13(89) (both 105 PFU/ml) and then V4B11(89) (5 x 102 PFU/ml) (Fig. 4) . Finally, the virus-specific RNAs as well as the S proteins produced in these infected Sac-cultures were compared electrophoretically (see legends to Fig. 1 and 2 (Fig. 5) . Antipeptide B serum identified coelectrophoresing S1 in MHV-4 and the single-resistance mutants; the increased mobility of S1 from the doubleresistance mutant was consistent with a 15-kDa deletion in this chain. Antipeptide C serum bound to coelectrophoresing S2 cleavage products from all virions; trimers of S2 were also seen in three of the four preparations. These analyses reinforced the contention that virus resistant to only one MAb contained point mutants, whereas virus resistant to both MAbs contained at least one deletion in S1 whose size and location was similar to that seen in the original 1986 mutants.
Variants with deletions in S are selectively amplified only in cell lines sensitive to virus-induced cell fusion. In four of six murine cell lines, we found MHV-4 to be highly cytopathic, with virus-induced cell fusion ultimately resulting in destruction of the cultures. These fusion-sensitive cultures included DBT and Sac-, two lines generally used for propagation of virus, as well as C1300 and Neuro 2A, two peripheral neuroblastoma cell lines. All of the deletion mutants, although cytopathic, exhibited a delayed induction of fusion in these four cell lines. By microscopic examination, this was most evident in the DBT cell line. After inoculation at high multiplicity, cell fusion reached 30% by 6 h postinfection in wild-type-infected cultures, whereas a similar degree of fusion was not observed until 12 h postinfection in parallel V5A13/4B11A(89)-infected cells (Fig. 6 ). Even after 24 h, when detached syncytia were all that remained in MHV-4-infected cultures, variant infection failed to recruit about half of DBT cells into syncytia (Fig. 6, bottom panels) .
Direct assays of viral titers produced in these fusionsensitive cell lines showed that delayed cytotoxicity was correlated with higher yields. In DBT and Sac-, the output titers of deletion variants V4B11.3A(86) and V5A13.1A (86) were 10 to 100 times higher than titers of wild-type MHV-4; in C1300 and Neuro 2A, the yields of deletion mutants were similarly 5-to 10-fold higher than yields of wild-type virus J. VIROL. ( Table 3 ). Essentially identical results were obtained with the reselected V5A13/4B11A(89) deletion mutant (data not shown).
NEUTRALIZATION-RESISTANT CORONAVIRUS VARIANTS
In contrast to the fusion-sensitive lines, two neuroblastomas derived from murine olfactory bulb, lines OBL 21 and OBL 21A, produced progeny virus in the absence of cytopathic effect or cell fusion. These two cultures produced similar but low yields of both wild-type and deletion mutant virus (Table 3 ). In addition, murine brains inoculated intracerebrally consistently produced more wild-type virus (Table 3). Together with the observations made for the fusing cell lines, these results suggest that the deletion mutants do not have an inherent ability to produce more progeny but rather that their reduced cytotoxicity simply allows cells to survive long enough for continuation of virion RNA, protein, and progeny PFU production.
This hypothesis was tested by monitoring the rate of virus-specific RNA synthesis in DBT (fusion-sensitive) and OBL 21A (fusion-resistant) cells infected with either wildtype or variant MHV. Such measurements are relatively straightforward because coronavirus mRNA synthesis is not blocked by dactinomycin, an inhibitor of DNA-directed RNA synthesis (27) . Thus, the incorporation of [3H]uridine into acid-insoluble material after dactinomycin treatment is indicative of viral RNA synthesis rates.
Incorporation studies showed that in the first 10 h of DBT infection, the kinetics of RNA synthesis were nearly identical for the two viruses; from 10 to 28 h postinfection, however, variant RNA synthesis continued, whereas wildtype RNA synthesis rapidly declined (Fig. 7A ). Viral RNA synthesis in MHV-4-infected DBT cultures was no longer detectable by 14 h postinfection; however, variant-specific RNA synthesis was observed even after 28 h. This RNA synthesis profile correlated well with the differential rate and extent of cell destruction in the two infections (Fig. 6 ). In addition, the time course was consistent with the observation of 100-fold-higher variant virus yields at 24 h postinfection (Table 3) . Infectivity of MHV is known to decline rapidly at 37°C in medium at neutral pH (32) . Thus, both the decreased overall production of MHV-4 and the longer period of progeny virus inactivation occurring between the end of the growth cycle and the time of virus harvest contributed to the lower yields of MHV-4.
In contrast to the DBT cells, daily monitoring of MHV-4 and variant RNA synthesis rates in OBL 21A cells revealed similar incorporation in the two cultures at 1 day postinfection ( Fig. 7B) . This result was consistent with the similar yields of the two virus types in this line ( Although the frequency of viable deletion mutants is clearly very low, we have found that these mutants nonetheless eventually amplify greatly in cell culture because of their ability to yield more progeny than does wild-type virus. This result clearly indicates that a 15-kDa domain in S fragment Si is dispensable for in vitro virus growth and that its presence actually limits virus growth in some but not all cell cultures. However, our finding that the replication of deletion mutants in the murine brain is poor relative to that of wild-type virus suggests that this portion of Si provides useful in vivo functions and that it would be maintained through serial in vivo passages. In this regard, it is notable that Taguchi et al. (36) isolated variants of MHV JHM from the brains of Lewis rats that contained S apoproteins 15 kDa larger than that seen in the virus stock used for inoculation. One likely explanation for this result is that predominantly deletion mutant inoculum was used and that selective replication of a minor component containing MHV-4-sized S occurred in the rat brain. In a separate study by Morris et al. (26) , virus was isolated from the spinal cord of persistently infected Wistar-Furth rats that harbored an S smaller than the inoculum used. Taken together, these results suggest that the host strain or the central nervous system location (brain or cord) may control S size selection in vivo.
Decreased cytopathic properties are a common feature of deletion mutants. All of our deletion mutants displayed a relatively weak cytopathic effect and a longer growth cycle, permitting higher yields of progeny virus than of wild-type virus. In addition, all of the mutants were significantly neuroattenuated when inoculated intracerebrally into BALB/c mice (7; T. Gallagher, unpublished observations). These characteristics are strikingly similar to those previously described for MHV JHM variants isolated from persistently infected Sac-(2) and DBT (12) cells. Our finding that infection of DBT cells with an S-deletion mutant leaves a high proportion of infected survivors ( Fig. 6 and 7) suggests that persistently infected cells may select for viruses lacking this dispensable Si domain. Clearly, one possibility that remains to be explored concerns the relative The correlation between the length and productivity of the MHV growth cycle and the degree of cytopathology was further reinforced by our finding that the two central nervous system neuronal lines, OBL 21 and 21A, which were resistant to the cytopathic effects of S, supported both wild-type and deletion mutant viruses with equal but low efficiency. Thus, it appears that one primary factor limiting the production of MHV-4 in vitro is its propensity to kill fusionsensitive cells before extensive virion formation occurs. At present, we know that MHV-4 synthesizes as much viral RNA and S protein as do the deletion mutants at the early stages of infection ( Fig. 2 and 7 ). In addition, preliminary pulse-chase analyses indicate that wild-type and mutant S proteins are transported intracellularly and incorporated into virions with identical kinetics. Therefore, we favor the hypothesis that omission of sequences in the Si fragment results in a decrease in the specific fusogenicity of the S molecule.
Point mutants will be useful for the precise identification of neutralizing epitopes. All available evidence supports the contention that our newly selected 1989 variants contain substitution mutations conferring resistance to neutralizing MAbs. Thus, the nucleotide sequence of these variant S genes, which is currently being determined, will no doubt provide a more precise identification of the epitopes defined by MAbs 4B11. 6 64, 1990 involved in neutralization has been mapped on the S sequence of MHV (20) . This MAb-binding site was conserved among all MHV strains. In contrast, the MAb 4B11.6 and 5A13.5 epitopes are found only on highly virulent strains of MHV (37) . Detailed analysis of these epitopes associated with virulence will contribute to an understanding of coronavirus pathogenesis.
